HONG KONG (MarketWatch) -- Shanghai stocks edged up Wednesday in quiet trading, following overnight gains on Wall Street, while most other Asian markets were closed for the Christmas holiday. The benchmark Shanghai Composite Index (CN:SHCOMP) rose 0.1% to 2093.92 in the morning session. Shares of cement companies advanced as China plans to start construction of more than 6 million affordable homes in 2014, according to state media Xinhua News Agency on Tuesday. Huaxin Cement (CN:600801) rose 1.3%, and Jidong Cement (CN:000401) advanced 1%. Jiangxi Wannianqing Cement (CN:000789) gained 0.5%. China's largest appliance maker Qingdao Haier (CN:600690) fell 0.5%, showing little reaction to the news that China's Commerce Ministry just approved the deal for U.S. private-equity giant KKR (KKR) to buy a 10% stake in the company for approximately $556 million. The transaction is still pending approval by the China Securities Regulatory Commission. China Railway Construction (CN:601186) edged up by 0.2%, after it announced Tuesday that it has won a Wuhan subway contract worth 7.1 billion yuan ($1.1 billion).
Best Asian Companies For 2015: Chelsea Therapeutics International Ltd.(CHTP)
Chelsea Therapeutics International, Ltd., a development-stage pharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutic products for the treatment of various human diseases. It is involved in developing Droxidopa, a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) associated with primary autonomic failure and falls related to NOH in Parkinson?s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension, fibromyalgia, adult attention deficit hyperactivity disorder, chronic fatigue syndrome, and freezing of gait in PD and down syndrome. The company intends to market its Droxidopa drug under the Northera brand name. It also engages in developing a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, including rheumatoid arthritis, psoriasis, Crohn?s disease, ankylosing spondylitis, uveitis, psoriatic arthritis, inflammatory bowel disease, cancer, and other immunological disorders. The company?s molecule products include a portfolio of metabolically inert antifolate molecules consisting of CH-1504 and CH-4051, which are orally available molecules with anti-inflammatory, autoimmune, and anti-tumor properties that inhibit various key enzymes required for cell proliferation; and a portfolio of dihydroorotate dehydrogenase, known as the I-3D portfolio, for applications in autoimmune diseases and transplantation. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.
Advisors' Opinion:- [By John Udovich]
The biotech roller-coaster continues for investors into 2014 with small cap Chelsea Therapeutics International Ltd (NASDAQ: CHTP) set to more than double when the market opens today, meaning its time to take a closer look at what in the world is going on with the stocks plus take a closer look at the performance of biotech peers like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By Roberto Pedone]
Chelsea Therapeutics (CHTP)
is a specialty pharmaceutical company focused on acquisition, development and commercialization of pharmaceutical products for the treatment of a variety of human diseases. This stock closed up 9% to $2.89 in Thursday's trading session.Thursday's Range: $2.55-$2.98
52-Week Range: $0.73-$3.25
Thursday's Volume: 1.74 million
Three-Month Average Volume: 1.14 millionFrom a technical perspective, CHTP ripped sharply higher here right off its 50-day moving average of $2.55 with above-average volume. This stock has been uptrending strong for the last two months, with shares moving higher from its low of $1.78 t its recent high of $3.25. During that move, shares of CHTP have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CHTP within range of triggering a major breakout trade. That trade will hit if CHTP manages to take out some near-term overhead resistance levels at $3 to its 52-week high at $3.25 with high volume.
Traders should now look for long-biased trades in CHTP as long as it's trending above its 50-day at $2.55 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.14 million shares. If that breakout triggers soon, then CHTP will set up to enter new 52-week-high territory above $3.25, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $4.21 to $4.40.
- [By Lauren Pollock]
Chelsea Therapeutics International Ltd.(CHTP) said an offering of 6.67 million shares priced at $3 each, a 9.9% discount to Tuesday’s close. The development-stage pharmaceutical company said it intends to use the proceeds to fund its droxidopa program, including regulatory and possible initial commercialization activity for its lead investigational drug candidate Northera, and for general corporate purposes. Shares dropped.
Best Asian Companies For 2015: Connecticut Water Service Inc. (CTWS)
Connecticut Water Service, Inc., through its subsidiaries, operates as a regulated water company in Connecticut. It operates in three segments: Water Activities, Real Estate Transactions, and Services and Rentals. The Water Activities segment supplies drinking water. The Real Estate Transactions segment involves in the sale or donation of its real estate holdings. The Services and Rentals segment provides contracted services to water and wastewater utilities and other clients, which include contract operations of water and wastewater facilities; Linebacker, an optional service line protection program that comprises repairing or replacing leaking or broken water service line, curb box, curb box cover, meter pit, meter pit cover, meter pit valve, and in-home water main shut off valve before the meter; and providing bulk deliveries of emergency drinking water to businesses and residences through tanker trucks. This segment also engages in leasing and renting residential and c ommercial properties. As of December 31, 2009, Connecticut Water Service, Inc. served 88,534 customers in 54 towns in Connecticut. The company was founded in 1956 and is headquartered in Clinton, Connecticut.
Advisors' Opinion:- [By David Dittman]
Note that water utilities and UF Portfolio Holdings American Water Works Co Inc (NYSE: AWK), Aqua America Inc (NYSE: WTR) and Connecticut Water Service Inc (NSDQ: CTWS) posted 2013 total returns of 16.1 percent, 18.8 percent and 23.1 percent, respectively, underperforming the broader S&P 500 but besting the traditional safe-haven subgroups.
- [By David Dittman]
Answer: Our favorite water utilities–American Water Works, Aqua America Inc (NYSE: WTR), Connecticut Water Service Inc (NSDQ: CTWS)–are solid dividend growers throughout the cycle, and they all have pretty good growth prospects because of the abundance of small-scale municipal water utilities in their footprints.
- [By David Dittman]
Answer: Water utilities have great track records of dividend growth: Aqua America, American Water Works Co Inc (NYSE: AWK) and Connecticut Water Service Inc (NSDQ: CTWS).
Top 10 Freight Companies To Watch In Right Now: CBRE Group Inc (CBG)
CBRE Group, Inc., incorporated on February 20, 2001, is a holding company that conducts all of its operations through its indirect subsidiaries. The Company is a commercial real estate services firm. The Company offers a range of services to occupiers, owners, lenders and investors in office, retail, industrial, multi-family and other types of commercial real estate. As of December 31, 2011, it operated approximately 300 offices worldwide, providing commercial real estate services under the CBRE brand name, investment management services under the CBRE Global Investors brand name and development services under the Trammell Crow brand name. CBRE Services, Inc., its direct wholly owned subsidiary, is also a holding company and is the primary obligor or issuer with respect to most of its long-term indebtedness. The Company operates in five segments: Americas, Europe, Middle East and Africa (EMEA), Asia Pacific, Global Investment Management and Development Services. In March 2014, the Company acquired VALTEQ Gesellschaft mbH and its subsidiaries.
The Americas
The Americas segment consisted of operations throughout the United States and Canada, as well as markets in Latin America. Its operations are wholly owned, but also include independent affiliated offices, which license the use of the CBRE and CB Richard Ellis names in their local markets in return for payments of annual royalty fees to the Company and an agreement to cross-refer business between the Company and the affiliate. Its advisory services businesses offer occupier/tenant and investor/owner services that meet the full spectrum of marketplace needs, including real estate services, capital markets and valuation. Within advisory services, its service lines are Real Estate Services, Capital Markets and Valuation.
The Company provides strategic advice and execution to owners, investors and occupiers of real estate in connection with leasing, disposition and acquisition of property. It generates revenue from ! existing United States real estate sales and leasing clients in 2011. This includes referrals from its contractual fee-for-services businesses, such as facilities and property management, mortgage loan servicing and investment management provided by CBRE Global Investors. The Company offers clients integrated investment sales and debt/equity financing services under the CBRE Capital Markets brand. The Company provides valuation services that include market value appraisals, litigation support, discounted cash flow analyses and feasibility and fairness opinions.
Outsourcing commercial real estate services is a long-term trend in its industry, with corporations, institutions, public sector entities, health care providers and others. Its outsourcing services primarily include two business lines that seek to capitalize on this trend: corporate services and asset services. The Company provides a suite of services to corporate users of real estate, including transaction management, project management, facilities management, strategic consulting, portfolio management and other services. Its clients are global corporations, health care providers and public sector entities with geographically-diverse real estate portfolios. Project management services are typically provided on a portfolio-wide or programmatic basis. Facilities management involves the day-to-day management of client-occupied space and includes headquarter buildings, regional offices, administrative offices and manufacturing and distribution facilities. The Company provides property management, construction management, marketing, leasing, accounting and financial services on a contractual basis for income-producing office, industrial and retail properties owned by local, regional and institutional investors. It provides these services through a network of real estate experts in markets throughout the United States.
Europe, Middle East and Africa (EMEA)
The Company�� Europe, Middle East and Africa, segment, ! operates ! in 44 countries with operations primarily conducted through a number of indirect wholly owned subsidiaries. The operations are located in France, Germany, Italy, the Netherlands, Russia, Spain and the United Kingdom. Its operations in these countries generally provide a range of services to the commercial property sector. Additionally, it provides some residential property services, primarily in France, Spain and the United Kingdom. Within EMEA, its services are organized along the same lines as in the Americas, including brokerage, investment properties, corporate services, valuation/appraisal services, asset management services and facilities management, among others.
In France, it has operations in Aix in Provence, Bagnolet, Bordeaux, Lille, Lyon, Marseille, Montreuil, Montrouge, Neuilly Sur Seine, Saint Denis and Toulouse. Its German operations are located in Berlin, Cologne, Dusseldorf, Frankfurt, Hamburg, Munich and Stuttgart. Its presence in Italy includes operations in Milan, Modena, Rome and Turin. Its operations in the Netherlands are located in Amsterdam, Almere, the Hague, Hoofddorp and Rotterdam. Itsoperations in Russia consist of an office in Moscow. In Spain, it provides full-service coverage through its offices in Barcelona, Madrid, Marbella, Palma de Mallorca and Valencia. The Company is a commercial real estate services company in the United Kingdom. In London, it provides a range of commercial property real estate services to investment and corporate clients.
The Company has affiliated offices that provide commercial real estate services under its brand name in several countries throughout Europe, the Middle East and Africa. Its agreements with these independent offices include licenses to use the CBRE and CB Richard Ellis names in the relevant territory in return for payments of annual royalty fees to the Company. In addition, these agreements also include business cross-referral arrangements between the Company and its affiliates.
Asia Pacific!
The Company�� Asia Pacific segment operates in 13 countries with operations primarily conducted through a number of indirect wholly owned subsidiaries. It is a provider a range of real estate services to corporations throughout the region, similar to the range of services provided by its Americas and EMEA segments. Its principal operations in Asia are located in China, Hong Kong, India, Japan, Singapore and South Korea. In addition, it has agreements with affiliate offices in the Philippines, Thailand, Vietnam, Cambodia and Malaysia that generate royalty fees and support cross-referral arrangements similar to its EMEA segment.
Global Investment Management
The Company�� operations in Global Investment Management segment are conducted through its indirect wholly owned subsidiary CBRE Global Investors, LLC and its global affiliates, which it also refers to as CBRE Global Investors. CBRE Global Investors provides investment management services to pension funds, insurance companies, sovereign wealth funds, foundations, endowments and other institutional investors seeking to generate returns and diversification through investment in real estate. It sponsors investment programs that span the risk/return spectrum across three continents: North America, Europe and Asia. CBRE Global Investors��investment programs are organized into four primary categories, which include direct real estate investments through separate accounts and sponsored equity and debt funds, as well as indirect real estate investments through listed securities and multi manager funds of funds. As of December 31, 2011, its portfolio of consolidated real estate held for investment consisted of one industrial property and three multi-family/residential properties, all located in the United States.
Development Services
The Company�� operations in Development Services segment are conducted through its indirect wholly owned subsidiaries Trammell Crow Company, Trammell Crow S! ervices, ! Inc. (both of which merged into Trammell Crow Company, LLC effective January 1, 2012) and certain of its subsidiaries, providing development services primarily in the United States to users of and investors in commercial real estate, as well as for its own account. Trammell Crow Company pursues opportunistic, risk-mitigated development and investment in commercial real estate across a wide spectrum of property types, including industrial, office and retail properties; healthcare facilities of all types (medical office buildings, hospitals and ambulatory surgery centers); higher education facilities (primarily student housing); and residential/mixed-use projects.
Trammell Crow Company acts as the manager of development projects, providing services that are in all stages of the process, including site identification, due diligence and acquisition; evaluating project feasibility, budgeting, scheduling and cash flow analysis; procurement of approvals and permits, including zoning and other entitlements; project finance advisory services; coordination of project design and engineering; construction bidding and management as well as tenant finish coordination; and project close-out and tenant move coordination. As of December 31, 2011, its portfolio of consolidated real estate consisted of land, industrial, office and retail properties and mixed-use projects.
The Company competes with Cushman & Wakefield, Jones Lang LaSalle and Grubb & Ellis.
Advisors' Opinion:- [By David Carey]
��undamentals turned positive in the second quarter of 2010, when demand growth outpaced supply growth for the first time in years,��said Kevin Mallory, global head of CBRE Hotels, the lodging-specialty practice of commercial-property brokerage CBRE Group Inc. (CBG) ��ncreased liquidity in the capital markets, combined with a recovery in fundamentals, has driven strong investor interest in hotel-sector investments.��
- [By Ben Levisohn]
Among stocks in the S&P 500, CBRE Group (CBG) has dropped 5.5% to $23.05 after it reported a profit of 30 cents a share, missing forecasts for 33 cents. Aflac (AFL), meanwhile, has fallen 3% to $65 after it reported a profit of $1.47, missing estimates for $1.48 on weakness in Japan. Plum Creek Timber (PCL) has dropped 1.3% to $45.76 after announcing that it would sell 12.1 million shares of stock at $45.
- [By John Udovich]
Midcaps CBRE Group Inc (NYSE: CBG) and Jones Lang LaSalle Inc (NYSE: JLL) are probably the better known real estate services stocks with the latter surging 12.36% yesterday on impressive earnings, but small cap stocks Kennedy-Wilson Holdings Inc (NYSE: KW) and FirstService Corporation (NASDAQ: FSRV) are also important real estate services providers that you may have overlooked. After all, real estate services stocks like the following would offer exposure to real estate by being invested in property as well as generating revenue from transactions, property management and other services: ��
Best Asian Companies For 2015: ImmunoCellular Therapeutics Ltd (IMUC)
ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient�� own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company�� products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient�� immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).
The Company in addition to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients��tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.
The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.
Advisors' Opinion:- [By Lauren Pollock]
ImmunoCellular Therapeutics Ltd.(IMUC) said its leading product candidate, a dendritic cell-based vaccine for brain cancer, didn’t show a statistically significant advantage in overall survival in a Phase II study. In a research note, Maxim Group said it is pushing its EU approval date target to 2019 and lowered its estimate on the stock to $12 a share from $18 a share. The stock plunged 62% to $1.04 premarket.
- [By Wallace Witkowski]
Shares of ImmunoCellular (IMUC) �jumped after the drug developer said data on a mid-stage brain cancer drug study were looking encouraging.
Best Asian Companies For 2015: Symmetricom Inc.(SYMM)
Symmetricom, Inc. provides timekeeping technologies, instruments, and solutions worldwide. Its Communications business unit provides timing technologies and services for communications infrastructure. The Communications business unit products comprise primary reference sources; edge clocks and distribution products for synchronization outside the network core; building integrated timing supply and sync supply unit for the central office; the PackeTime product suite; data over cable service interface specifications timing interface systems; network management and monitoring software; and embedded hardware and software solutions for integration with various elements of the communications ecosystem, such as silicon, routers, switches, microwave backhaul, and base stations. The company?s Government business unit offers time technology products for aerospace/defense, IT infrastructure, power infrastructure, and science and metrology applications. The Government business unit p roduct portfolio comprises timescale clock sources; network time servers; network time displays; time code generators; bus level timing cards; primary reference standards, such as rubidium and cesium oscillator standards; high stability masers; chip-scale atomic clocks; ruggedized crystal oscillators; and custom time and frequency systems. It offers timekeeping in GPS satellites, national time references, and national power grids, as well as in critical military and civilian networks, which enable data, voice, mobile, and video networks and services. The company sells its products through distributors, systems integrators, and manufacturer sales representatives. It serves various markets, including communications service providers; network equipment manufacturers; silicon suppliers; aerospace/defense; power utility infrastructure; IT infrastructure; underwater exploration and navigation; and science and metrology. The company was founded in 1956 and is headquartered in San J ose, California.
Advisors' Opinion:- [By Rich Smith]
San Jose, Calif.-based Symmetricom (NASDAQ: SYMM ) has a new chief executive officer.
On Tuesday, the "precise time" computer announced a series of changes in upper management. Current CEO David G. Cote is leaving the company "to pursue other interests" and has been replaced by new CEO Elizabeth A. Fetter, a current board member. Details on Fetter's compensation have yet to be filed with the SEC.
Best Asian Companies For 2015: Campbell Soup Co (CPB)
Campbell Soup Company (Campbell), incorporated on November 23, 1922, together with its subsidiaries, is a manufacturer and marketer of branded convenience food products. The Company operates in five segments: U.S. Simple Meals; Global Baking and Snacking; International Simple Meals and Beverages; U.S. Beverages; and North America Foodservice. In June 2012, the Company purchased 1300 Admiral Wilson Boulevard in Camden. On August 6, 2012, the Company completed the acquisition of BF Bolthouse Holdco LLC (Bolthouse Farms). In September 2012, Vilmorin & Cie SA acquired the tomato and pepper breeding and sales business of the Company. In June 2013, Campbell Soup Co completed the acquisition of Plum Organics. In August 2013, Campbell Soup Company completed the acquisition of Kelsen Group A/S.
In the United States, Canada and Latin America, the Company�� products are resold to consumers in retail food chains, mass discounters, mass merchandisers, club stores, convenience stores, drug stores, dollar stores and other retail, commercial and non-commercial establishments. In Europe, the Company�� products are resold to consumers in retail food chains, mass discounters, mass merchandisers, club stores, convenience stores and other retail, commercial and non-commercial establishments. In the Asia Pacific region, the Company�� products are resold to consumers through retail food chains, convenience stores and other retail, commercial and non-commercial establishments.
U.S. Simple Meals
The U.S. Simple Meals segment aggregates the operating segments: U.S. Soup and U.S. Sauces. The U.S. Soup retail business includes the products, such as Campbell�� condensed and ready-to-serve soups, and Swanson broth and stocks. The U.S. Sauces retail business includes Pregopasta sauces, Pace Mexican sauces, Campbell�� canned gravies, pasta, and beans, and Swanson canned poultry.
Global Baking and Snacking
The Global Baking and Snacking segment include Pepperi! dge Farm cookies, crackers, bakery and frozen products in the United States retail. It also includes Arnott�� biscuits in Australia and Asia Pacific.
International Simple Meals and Beverages
The International Simple Meals and Beverages segment aggregates the simple meals and beverages operating segments outside of the United States, including Europe, the retail business in Canada, and the businesses in Asia Pacific, Latin America and China. The segment�� operations include Erasco and Heisse Tasse soups in Germany,Liebig and Royco soups in France, Devos Lemmens mayonnaise and cold sauces and Campbell�� and Royco soups in Belgium, and Bla Band soups and sauces in Sweden. In Canada, operations include Habitant and Campbell�� soups, Prego pasta sauces, Pace Mexican sauces, V8 juices and beverages and certain Pepperidge Farm products. In Asia Pacific, operations include Campbell�� soup and stock, Kimball sauces, V8 juices and beverages, Prego pasta sauce and Swanson broths.
U.S. Beverages
The U.S. Beverages segment represents the United States retail beverages business, including V8 juices and beverages, and Campbell�� tomato juice.
North America Foodservice
The North America Foodservice segment represents the distribution of products, such as soup, specialty entrees, beverage products, other prepared foods and Pepperidge Farm products through food service channels in the United States and Canada.
Advisors' Opinion:- [By Reuters]
Toby Talbot/AP NEW YORK -- A voluntary effort by the world's largest food and beverage companies to remove billions of calories from the products they sell in the United States to help combat the nation's obesity epidemic has far exceeded its five-year goal, according to an independent evaluation released Thursday. In May 2010, 16 of the nation's biggest food and beverage companies, from Coca-Cola (KO) to Kraft Foods Group (KRFT), pledged to remove 1 trillion calories from the U.S. marketplace by 2012 and 1.5 trillion by 2015, compared with a 2007 baseline. In fact, as of 2012 they sold 6.4 trillion fewer calories, found an analysis by researchers at the University of North Carolina at Chapel Hill. "Reports like this, and the fact that they exceeded their commitment by fourfold, really shows that you can make progress in giving American families more healthy options," said Larry Soler, president of the Partnership for a Healthier America, a non-profit chaired by first lady Michelle Obama. The group was formed in 2010 to work with the private sector on anti-obesity strategies. At the time, critics said the Partnership relied too heavily on the good will of the industry and couldn't replace the role of tighter regulation on how food is manufactured and marketed. Such voluntary efforts by industry "are not a magic bullet," said Jeff Levi, executive director of Trust for America's Health, a non-profit policy group. "Particularly with kids, there is a role for regulation" in reducing demand for unhealthy, high-calorie fare. It isn't clear yet how the companies accomplished the dramatic calorie reduction, said UNC public health researcher Barry Popkin, who led the analysis funded by the Robert Wood Johnson Foundation, the nation's largest public health philanthropy. Some of the decline may have come from the recession, as financially strapped families cut back on junk food. When the pledge was announced, companies said they would substitute lower-calorie pro
- [By Rich Smith]
It might not be obvious to the casual observer, but right now, today, Campbell's (NYSE: CPB ) stock offers one of the best values available in the processed foods industry. Why?
Best Asian Companies For 2015: Sector Spdr Trust Sbi (XLI)
Industrial Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Industrial Select Sector of the S&P 500 Index (the Index). The Index includes companies from industries, such as aerospace and defense, building products, construction and engineering, electrical equipment, conglomerates, machinery, commercial services and supplies.
The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.
Advisors' Opinion:- [By Ben Levisohn]
GE has gained 9.5% this year after falling 0.7% to $22.98 today, well behind the SPDR S&P 500 ETF’s (SPY) 15% gain and the Industrial Select Sector SPDR’s (XLI) 17% rise. United Technologies (UTX) has risen 25% this year, while 3M (MMM) has advanced 22%.
- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some industrial stocks to your portfolio, the Industrial Select Sector SPDR ETF (NYSEMKT: XLI ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The SPDR ETF's expense ratio -- its annual fee -- is a very low 0.18%, and it recently yielded about 2%.
This ETF has performed well, outstripping the world market over the past three, five, and 10 years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.
No comments:
Post a Comment